190 related articles for article (PubMed ID: 11286478)
1. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
Akre K; Ekström AM; Signorello LB; Hansson LE; Nyrén O
Br J Cancer; 2001 Apr; 84(7):965-8. PubMed ID: 11286478
[TBL] [Abstract][Full Text] [Related]
2. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
3. Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.
Zaridze D; Borisova E; Maximovitch D; Chkhikvadze V
Int J Cancer; 1999 Aug; 82(4):473-6. PubMed ID: 10404057
[TBL] [Abstract][Full Text] [Related]
4. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
5. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden.
Ekström AM; Serafini M; Nyrén O; Hansson LE; Ye W; Wolk A
Int J Cancer; 2000 Jul; 87(1):133-40. PubMed ID: 10861464
[TBL] [Abstract][Full Text] [Related]
6. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
7. Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
Akre K; Signorello LB; Engstrand L; Bergström R; Larsson S; Eriksson BI; Nyrén O
Cancer Res; 2000 Nov; 60(22):6376-80. PubMed ID: 11103800
[TBL] [Abstract][Full Text] [Related]
8. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden.
Ekström AM; Hansson LE; Signorello LB; Lindgren A; Bergström R; Nyrén O
Br J Cancer; 2000 Aug; 83(3):391-6. PubMed ID: 10917557
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis.
Wang WH; Huang JQ; Zheng GF; Lam SK; Karlberg J; Wong BC
J Natl Cancer Inst; 2003 Dec; 95(23):1784-91. PubMed ID: 14652240
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
11. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
12. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
13. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
Abnet CC; Freedman ND; Kamangar F; Leitzmann MF; Hollenbeck AR; Schatzkin A
Br J Cancer; 2009 Feb; 100(3):551-7. PubMed ID: 19156150
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.
Epplein M; Nomura AM; Wilkens LR; Henderson BE; Kolonel LN
Am J Epidemiol; 2009 Aug; 170(4):507-14. PubMed ID: 19584132
[TBL] [Abstract][Full Text] [Related]
16. Dietary patterns and gastric cancer in a Portuguese urban population.
Bastos J; Lunet N; Peleteiro B; Lopes C; Barros H
Int J Cancer; 2010 Jul; 127(2):433-41. PubMed ID: 19876925
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1-beta gene polymorphisms and risk of gastric cancer in Sweden.
Persson C; Engstrand L; Nyrén O; Hansson LE; Enroth H; Ekström AM; Ye W
Scand J Gastroenterol; 2009; 44(3):339-45. PubMed ID: 19031173
[TBL] [Abstract][Full Text] [Related]
18. Occupational exposures and risk of gastric cancer in a population-based case-control study.
Ekström AM; Eriksson M; Hansson LE; Lindgren A; Signorello LB; Nyrén O; Hardell L
Cancer Res; 1999 Dec; 59(23):5932-7. PubMed ID: 10606238
[TBL] [Abstract][Full Text] [Related]
19. Regular aspirin use and stomach cancer risk in China.
Wang Y; Shen C; Ge J; Duan H
Eur J Surg Oncol; 2015 Jun; 41(6):801-4. PubMed ID: 25796983
[TBL] [Abstract][Full Text] [Related]
20. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study.
Kono Y; Okada H; Takenaka R; Miura K; Kanzaki H; Hori K; Kita M; Tsuzuki T; Kawano S; Kawahara Y; Yamamoto K
Gut Liver; 2016 Jan; 10(1):69-75. PubMed ID: 26087789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
